ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,997Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 252

$605K Total Retail Price of All Prescriptions

Rank: 72 out of 252

433 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 433 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,136 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
OMEPRAZOLE 528 444 1 6
LEVOTHYROXINE SODIUM 477 400 2 1
FUROSEMIDE 413 333 3 7
SIMVASTATIN 400 323 4 2
LISINOPRIL 397 294 5 3
CITALOPRAM HBR 362 303 6 15
AMLODIPINE BESYLATE 312 258 7 4
HYDROCHLOROTHIAZIDE 278 251 8 13
CARVEDILOL 250 200 9 22
GABAPENTIN 249 207 10 11
POTASSIUM CHLORIDE 237 177 11 8
HYDROCODONE-ACETAMINOPHEN 197 121 S3 12 5
ZOLPIDEM TARTRATE 184 122 13 21
METOPROLOL TARTRATE 182 155 14 10
METFORMIN HCL 173 111 15 9
TRAMADOL HCL 171 106 16 17
GLYBURIDE 167 105 R 17 78
CLOPIDOGREL 156 125 18 29
PLAVIX 137 120 19 43
LOSARTAN POTASSIUM 132 132 20 24
LANTUS 131 122 21 55
ISOSORBIDE MONONITRATE ER 129 104 22 50
PRAVASTATIN SODIUM 127 114 23 12
NEXIUM 126 68 24 23
CRESTOR 124 74 25 34
WARFARIN SODIUM 119 104 26 14
ATENOLOL 107 82 27 18
METOPROLOL SUCCINATE 101 71 28 19
PANTOPRAZOLE SODIUM 101 73 28 62
CIPROFLOXACIN HCL 98 74 30 61
ALLOPURINOL 91 73 31 30
CYCLOBENZAPRINE HCL 86 34 R 32 51
DIOVAN 84 70 33 38
TAMSULOSIN HCL 84 82 33 26
CEPHALEXIN 83 56 35 121
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 69 36 25
LYRICA 79 57 37 66
RANITIDINE HCL 76 69 38 48
MELOXICAM 75 74 39 20
JANUMET 73 60 40 233
ESCITALOPRAM OXALATE 72 59 41 56
FLUTICASONE PROPIONATE 71 59 42 36
AZITHROMYCIN 71 50 42 37
NOVOLOG 71 62 42 106
GLIPIZIDE 69 59 45 52
INSULIN SYRINGE 65 62 46 93
JANUVIA 64 42 47 88
ALENDRONATE SODIUM 63 63 48 32
SYMBICORT 60 42 49 137
TOPIRAMATE 59 31 50 151
QUETIAPINE FUMARATE 58 43 51 77
COMBIVENT 57 47 52 123
ESTRADIOL 56 33 R 53 76
AMLODIPINE BESYLATE-BENAZEPRIL 55 50 54 60
DONEPEZIL HCL 55 55 54 28
SERTRALINE HCL 55 43 54 27
SYNTHROID 54 52 57 47
PRAMIPEXOLE DIHYDROCHLORIDE 53 50 58 163
ENALAPRIL MALEATE 52 50 59 72
CLONIDINE HCL 51 19 60 35
DEXILANT 51 13 60 260
DIGOXIN 50 40 62 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.